Quantbot Technologies LP Buys 16,904 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Quantbot Technologies LP grew its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 82.6% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 37,375 shares of the company’s stock after acquiring an additional 16,904 shares during the period. Quantbot Technologies LP’s holdings in Privia Health Group were worth $681,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of PRVA. Nisa Investment Advisors LLC boosted its position in Privia Health Group by 107.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock worth $31,000 after buying an additional 930 shares during the period. Louisiana State Employees Retirement System increased its stake in shares of Privia Health Group by 2.6% in the second quarter. Louisiana State Employees Retirement System now owns 52,200 shares of the company’s stock valued at $907,000 after buying an additional 1,300 shares during the period. Allspring Global Investments Holdings LLC lifted its position in shares of Privia Health Group by 8.8% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 9,758 shares of the company’s stock worth $170,000 after purchasing an additional 788 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Privia Health Group by 7.5% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,742 shares of the company’s stock valued at $413,000 after acquiring an additional 1,653 shares during the last quarter. Finally, Peregrine Capital Management LLC boosted its position in shares of Privia Health Group by 11.5% during the 2nd quarter. Peregrine Capital Management LLC now owns 314,190 shares of the company’s stock valued at $5,461,000 after purchasing an additional 32,311 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Wall Street Analysts Forecast Growth

PRVA has been the topic of several research analyst reports. KeyCorp began coverage on shares of Privia Health Group in a research note on Friday, October 11th. They set an “overweight” rating and a $23.00 target price on the stock. Truist Financial lifted their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Robert W. Baird increased their price objective on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 26th. Royal Bank of Canada reissued an “outperform” rating and issued a $28.00 target price on shares of Privia Health Group in a research note on Wednesday, August 14th. Finally, Barclays raised their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Two research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $24.93.

Privia Health Group Price Performance

Privia Health Group stock opened at $22.31 on Tuesday. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.30. The business’s fifty day moving average is $19.24 and its 200 day moving average is $18.71. The stock has a market capitalization of $2.68 billion, a PE ratio of 223.10, a price-to-earnings-growth ratio of 5.40 and a beta of 0.76.

Insider Transactions at Privia Health Group

In other news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the transaction, the chief executive officer now directly owns 247,771 shares in the company, valued at $4,583,763.50. This trade represents a 35.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Company insiders own 14.20% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.